Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes
Transition of cytosine to thymine in CpG dinucleotides is the most frequent type of mutation in cancer. This increased mutability is commonly attributed to spontaneous deamination of 5-methylcytosine (5mC), which is normally repaired by the base-excision repair (BER) pathway. However, the contribution of 5mC deamination in the increasing diversity of cancer mutational signatures remains poorly explored. Here, we integrate mutational signatures analysis in a large series of tumor whole genomes with lineage-specific epigenomic data to draw a detailed view on 5mC deamination in cancer. We uncover tumor type-specific patterns of 5mC deamination signatures in CpG and non-CpG contexts. We demonstrate that the BER glycosylase MBD4 preferentially binds to open chromatin domains, which correlates with lower mutational burden in these domains. We validate our findings by modelling BER deficiencies in isogenic cell models. Overall, we establish MBD4 as the main actor responsible for 5mC deamination repair in humans.
- Type: Cancer Genomics
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD50000000763 | Illumina NovaSeq 6000 | 9 | |
EGAD50000000764 | Illumina NovaSeq 6000 | 2 | |
EGAD50000000765 | Illumina NovaSeq 6000 | 20 | |
EGAD50000000766 | DNBSEQ-T7 | 1 | |
EGAD50000000767 | Illumina HiSeq 2000 Illumina HiSeq 2500 Illumina NovaSeq 6000 | 21 |
Publications | Citations |
---|---|
Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes.
Nat Commun 15: 2024 9864 |
0 |